T. Rowe Price Health Care ETF · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, T. Rowe Price Health Care ETF (TMED) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | LLY | 14.48% | $3M |
| 2 | UNH | 6.54% | $1M |
| 3 | TMO | 4.59% | $930K |
| 4 | GILD | 4.14% | $839K |
| 5 | ABT | 3.91% | $793K |
| 6 | DHR | 2.73% | $553K |
| 7 | MDT | 2.24% | $454K |
| 8 | ALNY | 2.06% | $418K |
| 9 | SYK | 2.00% | $406K |
| 10 | DYN | 1.88% | $380K |
| 11 | WAT | 1.75% | $355K |
| 12 | BDX | 1.71% | $346K |
| 13 | A | 1.69% | $341K |
| 14 | ELAN | 1.59% | $321K |
| 15 | HUM | 1.57% | $318K |
| 16 | CYTK | 1.54% | $311K |
| 17 | WST | 1.48% | $300K |
| 18 | BSX | 1.47% | $298K |
| 19 | ASCENDIS PHARMA A/S - ADR | 1.39% | $282K |
| 20 | BIIB | 1.26% | $255K |
| 21 | PCVX | 1.19% | $240K |
| 22 | IMNM | 1.15% | $233K |
| 23 | MTD | 1.11% | $224K |
| 24 | CENCORA INC | 1.06% | $215K |
| 25 | APELLIS PHARMACEUTICALS INC | 1.03% | $208K |
Showing 25 of 103 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
Daily range, ATR, beta, and the math for a 1-ADR stop.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TMED Jan avg: -0.60% median: -0.60% win: 0% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 | TMED Feb avg: 3.19% median: 3.19% win: 100% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 | TMED Mar avg: -5.12% median: -5.12% win: 0% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 | TMED Apr avg: 3.73% median: 3.73% win: 100% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 | TMED May avg: 5.50% median: 5.50% win: 100% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 | TMED Jun avg: 3.31% median: 3.31% win: 50% σ: 6.45% n: 2 2025-06-13 → 2026-07-31 | TMED Jul avg: -1.98% median: -1.98% win: 0% σ: 1.68% n: 2 2025-06-13 → 2026-07-31 | TMED Aug avg: 5.03% median: 5.03% win: 100% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 (current) | TMED Sep avg: 5.71% median: 5.71% win: 100% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 | TMED Oct avg: 7.30% median: 7.30% win: 100% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 | TMED Nov avg: 6.21% median: 6.21% win: 100% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 | TMED Dec avg: -2.23% median: -2.23% win: 0% σ: 0.00% n: 1 2025-06-13 → 2026-07-31 |
Holdings of TMED currently on TickerStance stock-RS leaderboards.
Metrics matched 93 tickers across 103 holdings rows (94.7% of fund weight). Metrics as of 2026-08-24; holdings from the filing.